A Study to Compare the Amount of Prazosin Hydrochloride in Participants’ Blood After Taking Capsules Manufactured at Different Sites.
A Study to Compare the Amount of Prazosin Hydrochloride in Participants’ Blood After Taking
Capsules Manufactured at Different Sites. A 2 Cohort, Single Dose, Open-Label, Randomized,
Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer from Barceloneta to Ascoli for Prazosin Hydrochloride Capsules in Healthy Adult Participants Under Fasted Conditions.
Category & Conditions: Cardiovasular Diseases and Conditions
Medicine: MINIPRESS®(PRAZOSIN HYDROCHLORIDE)
ClinicalTrials.gov Identifier (NCT): NCT04967443
Protocol ID: A0281006
PrintDownloadOpen Plain Language Summary Result: Click here